<p>弗雷泽尼乌斯医疗护理股份公司（ETR:FME - 获取免费报告）在周二的交易中，股价突破了其 200 日移动平均线。该股票的 200 日移动平均线为 41.84 欧元（45.48 美元），最高交易价为 44.45 欧元（48.32 美元）。弗雷泽尼乌斯医疗护理的最后交易价为 44.07 欧元（47.90 美元），成交量为 465,526 股。</p>
<p>获取 <strong>弗雷泽尼乌斯医疗护理</strong> 的提醒：</p>
<h2>弗雷泽尼乌斯医疗护理股价上涨 1.5%</h2>
<p>该公司的债务股本比率为 82.24，速动比率为 0.80，流动比率为 1.37。该股票的市值为 133.9 亿美元，市盈率为 20.32，市盈增长比率为 0.42，贝塔值为 0.86。该公司的 50 日简单移动平均线为 45.29 欧元，200 日简单移动平均线为 41.86 欧元。</p>
<h2>关于弗雷泽尼乌斯医疗护理</h2>
<p>（获取免费报告）</p>
<p>弗雷泽尼乌斯医疗护理股份公司在德国、北美及国际上为肾脏疾病患者提供透析及相关服务。该公司通过门诊透析诊所网络提供透析治疗及相关实验室和诊断服务；提供材料、培训和患者支持服务，包括临床监测、后续协助以及安排将物资送到患者住所；并为美国医院的住院终末期肾病（ESRD）患者和急性肾衰竭患者提供合同透析服务。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票，胜过弗雷泽尼乌斯医疗护理</li>
<li>这些液化天然气股票准备迎来反弹吗？</li>
<li>亚马逊股票的所有信号都表明买入——是时候加仓了吗？</li>
<li>如何做空纳斯达克：简单易懂的指南</li>
<li>五个理由说明 Five Below 的股价今年将上涨</li>
<li>揭示 VWAP 的力量：交易者的关键指标</li>
<li>博通：为什么这只芯片股票仍然是长期 AI 投资的首选</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在弗雷泽尼乌斯医疗护理吗？</h2>
<p>在考虑弗雷泽尼乌斯医疗护理之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而弗雷泽尼乌斯医疗护理并不在名单上。</p>
<p>虽然弗雷泽尼乌斯医疗护理目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Fresenius Medical Care (ETR:FME) 的股票已超过其 200 日移动平均线，交易价格为 44.07 欧元（47.90 美元），成交量为 465,526 股。该公司的市值为 133.9 亿美元，市盈率为 20.32。该公司专注于全球肾病患者的透析服务。尽管股价走势积极，分析师目前对该股票的评级为持有，建议投资者考虑其他更好的投资选择</p>

<p>Fresenius Medical Care AG (ETR:FME - Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of €41.84 ($45.48) and traded as high as €44.45 ($48.32). Fresenius Medical Care shares last traded at €44.07 ($47.90), with a volume of 465,526 shares.</p>
<div class="lb-trans"><p>弗雷泽尼乌斯医疗护理股份公司（ETR:FME - 获取免费报告）在周二的交易中，股价突破了其 200 日移动平均线。该股票的 200 日移动平均线为 41.84 欧元（45.48 美元），最高交易价为 44.45 欧元（48.32 美元）。弗雷泽尼乌斯医疗护理的最后交易价为 44.07 欧元（47.90 美元），成交量为 465,526 股。</p>
</div><p>Get <strong>Fresenius Medical Care</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>弗雷泽尼乌斯医疗护理</strong> 的提醒：</p>
</div><h2>Fresenius Medical Care Trading Up 1.5 %</h2>
<div class="lb-trans"><h2>弗雷泽尼乌斯医疗护理股价上涨 1.5%</h2>
</div><p>The company has a debt-to-equity ratio of 82.24, a quick ratio of 0.80 and a current ratio of 1.37. The stock has a market capitalization of $13.39 billion, a P/E ratio of 20.32, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86. The business has a 50 day simple moving average of €45.29 and a 200-day simple moving average of €41.86.</p>
<div class="lb-trans"><p>该公司的债务股本比率为 82.24，速动比率为 0.80，流动比率为 1.37。该股票的市值为 133.9 亿美元，市盈率为 20.32，市盈增长比率为 0.42，贝塔值为 0.86。该公司的 50 日简单移动平均线为 45.29 欧元，200 日简单移动平均线为 41.86 欧元。</p>
</div><h2>About Fresenius Medical Care</h2>
<div class="lb-trans"><h2>关于弗雷泽尼乌斯医疗护理</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.</p>
<div class="lb-trans"><p>弗雷泽尼乌斯医疗护理股份公司在德国、北美及国际上为肾脏疾病患者提供透析及相关服务。该公司通过门诊透析诊所网络提供透析治疗及相关实验室和诊断服务；提供材料、培训和患者支持服务，包括临床监测、后续协助以及安排将物资送到患者住所；并为美国医院的住院终末期肾病（ESRD）患者和急性肾衰竭患者提供合同透析服务。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Fresenius Medical Care</li>
<li>Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?</li>
<li>Everything About Amazon Stock Signals a Buy—Time to Load Up?</li>
<li>How to Short Nasdaq: An Easy-to-Follow Guide</li>
<li>5 Reasons Five Below’s Stock Price Is Heading Higher This Year</li>
<li>Unveiling The Power Of VWAP: A Key Indicator For Traders</li>
<li>Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过弗雷泽尼乌斯医疗护理</li>
<li>这些液化天然气股票准备迎来反弹吗？</li>
<li>亚马逊股票的所有信号都表明买入——是时候加仓了吗？</li>
<li>如何做空纳斯达克：简单易懂的指南</li>
<li>五个理由说明 Five Below 的股价今年将上涨</li>
<li>揭示 VWAP 的力量：交易者的关键指标</li>
<li>博通：为什么这只芯片股票仍然是长期 AI 投资的首选</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Fresenius Medical Care Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在弗雷泽尼乌斯医疗护理吗？</h2>
</div><p>Before you consider Fresenius Medical Care, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑弗雷泽尼乌斯医疗护理之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而弗雷泽尼乌斯医疗护理并不在名单上。</p>
</div><p>While Fresenius Medical Care currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然弗雷泽尼乌斯医疗护理目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Fresenius Medical Care (ETR:FME) 股价突破两百日移动平均线 - 事情是这样的